Patent · US Active

2-amino—5-substituted pyrimidine inhibitors

US8030487B2 · kind B2 · utility

9Cited by

2References

34Claims

0Family size

Assignee

TargeGen, Inc. · US

Inventors

Glenn Noronha · Atlanta, US
Jianguo Cao · San Diego, US
Colleen Gritzen · Vista, US
Chi Ching Mak · San Diego, US
Andrew McPherson · San Diego, US
Ved Pathak · San Diego, US
Joel Renick · San Diego, US
Richard Soll · San Diego, US
Binqi Zeng · San Diego, US
Elena Dneprovskaia · San Diego, US

Key dates

Filing date	Jul 2, 2007
Grant date	Oct 4, 2011
Priority date	—
Expiry date	Feb 20, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds having the general structure (A) are provided. The compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, Vegfr and various other specific receptor and non-receptor kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.